JBT Corporation — FY 2022 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2022. This is an annual report, not a standalone fourth-quarter earnings report; the filing notes that revenue and operating income are historically highest in Q4. The registrant is John Bean Technologies Corporation (JBT), operating FoodTech and AeroTech businesses.
Business context
FoodTech supplies food and beverage processing, packaging, automation, equipment and aftermarket services. AeroTech supplies airport and aviation equipment and services. Recurring revenue represented 47% of FoodTech revenue and 38% of AeroTech revenue in 2022. International sales were 36% of total revenue.
Key financial results
| Metric | 2022 | 2021 | Change |
|---|---|---|---|
| Revenue | $2,166.0 million | $1,868.3 million | +15.9% |
| Gross profit / margin | $617.3 million / 28.5% | $566.8 million / 30.3% | Margin down 180 bps |
| Operating income / margin | $168.4 million / 7.8% | $160.1 million / 8.6% | Income +5.2%; margin down 80 bps |
| Net income | $130.7 million | $118.4 million | +10.4% |
| Diluted EPS | $4.07 | $3.69 | +10.3% |
| Operating cash flow | $142.3 million | $225.7 million | Down $83.4 million |
| Cash and cash equivalents | $73.1 million | $78.8 million | Down $5.7 million |
Revenue growth included $282.0 million of organic growth and $93.5 million from acquisitions, partly offset by $77.8 million of unfavorable foreign-currency translation. Higher material, freight and labor costs, supply-chain disruption, and a mix shift toward lower-margin non-recurring revenue pressured gross margin. Net interest expense rose to $14.2 million from $8.7 million, reflecting higher rates and acquisition-related borrowing. The effective tax rate fell to 15.3% from 22.4%, primarily due to beneficial discrete items.
- FoodTech: Revenue was $1,590.6 million, up 13.6%; segment operating profit was $211.5 million, up 13.1%, while margin edged down to 13.3% from 13.4%.
- AeroTech: Revenue was $575.7 million, up 23.1%; segment operating profit was $43.5 million, up 33.4%, and margin improved to 7.6% from 7.0%, supported by recovery in aviation markets.
Cash, debt and liquidity
At year-end, gross borrowings were $987.1 million: $584.6 million drawn on the revolving facility and $402.5 million of 0.25% convertible notes due 2026. The balance sheet reported $977.3 million of long-term debt, net of issuance costs, plus $0.6 million of short-term debt. The revolver had $709.0 million of stated availability, subject to covenants; management reported total liquidity of $526.3 million. JBT said it was in compliance with credit covenants and expected to remain compliant.
Investing cash outflow was $416.1 million, including $329.7 million for acquisitions and $87.6 million of capital expenditures. Financing cash inflow was $270.6 million, driven mainly by higher borrowing to fund acquisitions. The filing attributes lower operating cash flow chiefly to increased inventory and receivables. A tax-law change requiring U.S. R&D costs to be amortized reduced 2022 operating cash flow by about $25 million; management expected a further reduction of about $20 million in 2023.
Material changes, outlook and management commentary
- Inbound orders were $2,182.5 million, broadly level with 2021 as reported; FoodTech orders grew on a constant-currency basis, while AeroTech orders increased. Year-end backlog rose to $1,054.9 million from $1,006.7 million; JBT expected to recognize 84% of each segment’s backlog as revenue in 2023.
- Management anticipated continued revenue growth in 2023, citing sustained demand and strong opening backlog. The filing provides no quantified 2023 revenue or earnings guidance in the text presented.
- Planned 2023 capital expenditures were $60–$70 million, including $12–$14 million for the OmniBlu digital platform. Management identified a medium-term opportunity to improve operating margins by 200 basis points or more, largely through sourcing and productivity initiatives.
- A 2022–2023 FoodTech restructuring plan had incurred $5.4 million by year-end, with total costs estimated at $8–$10 million and cumulative savings estimated at $9–$12 million. Management expected $5–$6 million of savings in 2023 and the balance in 2024.
- JBT was evaluating strategic alternatives for AeroTech, with the assessment expected to conclude in the first half of 2023. The company suspended commercial activity in Russia, Belarus and occupied regions of Ukraine; management said the direct financial impact was and was expected to remain immaterial.
- 2022 acquisitions included Bevcorp and Alco. Bevcorp’s $288.1 million net consideration included a $127.0 million customer-relationship intangible; its purchase accounting remained provisional. The acquisitions contributed $53.7 million of 2022 revenue and $2.0 million of operating income in aggregate.
Risks, contingencies and unusual items
Principal risks include continuing supply-chain delays and inflation, labor shortages and higher labor costs, fixed-price contract overruns, weaker customer demand amid economic or energy-cost pressures, foreign-exchange exposure, and execution risks in acquisitions, restructuring and OmniBlu development. The AeroTech strategic review and uncertainty around its timing and outcome are also relevant. Debt covenants, variable-rate borrowing, convertible-note dilution and significant goodwill and intangible assets merit attention.
Contractual and other obligations totaled $1,330.2 million, including $977.3 million of long-term debt payments, $107.7 million of estimated interest, $197.2 million of pension and post-retirement obligations, and $48.0 million of operating lease payments. Letters of credit, bank guarantees and surety bonds totaled $136.8 million. Management did not expect pending legal proceedings, individually or collectively, to have a material adverse effect, while noting an unfavorable resolution could materially affect a particular future period. The independent auditor gave unqualified opinions on the financial statements and internal control; Alco and Bevcorp were excluded from the year-end control assessment because they were acquired during 2022.
Important facts for investors to verify
- Whether backlog converts on schedule and the 2023 revenue-growth outlook is achieved, particularly given supply and labor constraints.
- Whether gross margins recover as pricing, productivity and sourcing actions offset input-cost pressures.
- The outcome and timing of the AeroTech strategic alternatives review and any resulting financial or operational effects.
- Acquisition integration and returns, including final purchase accounting for Bevcorp and Alco.
- Operating cash-flow conversion, working-capital requirements, R&D tax-related cash effects, and liquidity and covenant headroom.
- OmniBlu investment, customer adoption and subscription-revenue contribution, alongside the expected restructuring costs and savings.